Home/Filings/4/0001562180-21-007876
4//SEC Filing

Fox Allan M. 4

Accession 0001562180-21-007876

CIK 0001590877other

Filed

Dec 26, 7:00 PM ET

Accepted

Dec 27, 4:16 PM ET

Size

12.2 KB

Accession

0001562180-21-007876

Insider Transaction Report

Form 4
Period: 2021-12-22
Fox Allan M.
Director
Transactions
  • Sale

    Common Stock

    2021-12-23$35.85/sh6,323$226,6641,529,981 total(indirect: By LLC)
  • Sale

    Common Stock

    2021-12-23$34.92/sh44,908$1,568,1201,536,304 total(indirect: By LLC)
  • Sale

    Common Stock

    2021-12-22$34.40/sh61,638$2,120,5751,581,212 total(indirect: By LLC)
Holdings
  • Common Stock

    (indirect: By Trust)
    315,000
  • Common Stock

    (indirect: By Trust)
    315,000
  • Common Stock

    (indirect: By Trust)
    722,485
Footnotes (4)
  • [F1]This transaction was executed in multiple trades at prices ranging from $34.01 to $34.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F3]This transaction was executed in multiple trades at prices ranging from $34.75 to $35.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]This transaction was executed in multiple trades at prices ranging from $35.75 to $36.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Issuer

REGENXBIO Inc.

CIK 0001590877

Entity typeother

Related Parties

1
  • filerCIK 0001652936

Filing Metadata

Form type
4
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 4:16 PM ET
Size
12.2 KB